Skip to main content
UROY logo

UROY · Uranium Royalty Corp. · Financials

Track UROY — free
$3.57 -0.13 (-3.51%) At close · Oct 28
Market Cap
$1.33B
Shares
377.21M
Volume · Oct 28 2.88M Avg daily vol (3M) 3.31M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$186.81M +1566%
FY2026 Revenue FY2024–FY2026
Net Income
$40.25M +992.6%
FY2026 Net Income FY2024–FY2026
Operating Margin
25.87% +56.6pp
FY2026 Operating Margin FY2024–FY2026
Diluted EPS
$0.29 +825%
FY2026 Diluted EPS FY2024–FY2026
Operating Cash Flow
$178.46M +1285%
FY2026 Operating Cash Flow FY2024–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 FY2025 FY2024
$186.81M $11.21M $31.21M
$5.29M $4.8M $4.97M
$111K $47K $0
$48.32M -$3.44M $5.09M
25.87% -30.71% 16.31%
$48.43M -$3.4M $5.09M
$0 $303K $0
$2M $414K $513K
$0 $158K $147K
$8.91M -$1.85M $11.3M
$54.64M -$5.64M $16.9M
$14.39M -$1.14M $3.2M
$40.25M -$4.51M $13.71M
21.55% -40.21% 43.92%
$42.93M -$4.62M $10.71M
USD/shares $0.29 -$0.04 $0.13
USD/shares $0.29 -$0.04 $0.12
shares 138.95M 126.8M 108.64M
shares 139.42M 126.8M 115.16M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current operating lease liabilities 2026-07-31 USD 44,000 10-Q filed 2026-09-14
Current portion of long-term debt 2026-07-31 USD 17,097,000 10-Q filed 2026-09-14
Noncurrent debt carrying amount 2026-07-31 USD 535,661,000 10-Q filed 2026-09-14
Noncurrent operating lease liabilities 2026-07-31 USD 56,000 10-Q filed 2026-09-14
Short-term borrowings 2026-07-31 USD 40,000,000 10-Q filed 2026-09-14
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
8.58×
Peer median 4.56×
EV/EBIT
29.32×
P/E (TTM)
—

Peer medians compare against the 6 similar-size Uranium companies (of 9 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component FY2026 FY2025 FY2024
Sales of Uranium Inventory $186,807,000 $11,213,000 $31,205,000
Royalty $145,000 $63,000 $4,000
Key facts CIK 2143673 CUSIP 91703D100 13F (30d) 12 filings 12 filers Visit website Investor relations